Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center Where you're treated first, matters. To make an appointment, call (844)-422-9799
(4277)

Connect with us:
www.mskcc.org
https://twitter.com/MSKCancerCenter
www.instagram.com/memorialsloankettering
youtube.com/user/mskcc

Our main campus and inpatient hospital are located on the Upper East Side of Manhattan. We also have outpatient facilities in Commack, Uniondale, and Hauppauge on Long Island, New York; West Harrison in Westchester County, New York; and Basking Ridge, Montvale, and Middletown in New Jersey; as well as several locations in New York City.

During National Volunteer Recognition Week, MSK proudly celebrated our volunteers at the 53rd Annual Volunteer Recogniti...
04/24/2026

During National Volunteer Recognition Week, MSK proudly celebrated our volunteers at the 53rd Annual Volunteer Recognition Ceremony, sponsored by The Society of MSK.

With 100+ guests in attendance, staff and volunteer speakers shared just how impactful our volunteers are across MSK. We honored service milestones of 5, 10, 15, 20, and 25 years—and even welcomed our Caring Canines as they walked the blue carpet.

Volunteers truly are the heart of MSK, and we are so grateful for them. Share a 💙 below for these volunteers.

As we celebrate Laboratory Professionals Week, we honor the dedicated technologists and support staff who make up our la...
04/23/2026

As we celebrate Laboratory Professionals Week, we honor the dedicated technologists and support staff who make up our laboratory team at MSK.

Behind the scenes, these skilled experts process thousands of specimens daily, generating the critical data that guides oncologists in diagnosing cancer, determining treatment plans, and monitoring patient progress.

Their vital contributions play a crucial role in patient care, and they work tirelessly to ensure accurate diagnostics and better treatment outcomes.

Share a 🔬 below for our MSK lab professionals!

Thirteen years ago, Prena showed up to her first Cycle for Survival ride not knowing just how meaningful it would become...
04/23/2026

Thirteen years ago, Prena showed up to her first Cycle for Survival ride not knowing just how meaningful it would become in her life.

When she was diagnosed with thyroid cancer in 2010, Prena was a single mom experiencing symptoms such as severe weight fluctuations.

After an unpleasant experience at a local hospital, a colleague encouraged her to switch her care to MSK. Not long after, something unexpected caught her attention. On her commute to work, she saw a sign for Cycle for Survival, MSK’s official rare cancer fundraising event.

“The stars aligned,” she says. Prena signed up for her first ride and never looked back.

She began building a team and connecting with the Cycle for Survival community. In 2019, she shared her story onstage at a Cycle for Survival event in New York City. Prena has participated in Cycle for Survival for 14 years and will continue to give back and help others.

“It’s really fun, but it’s also emotional and empowering.”

For Prena, Cycle for Survival is a way to show up for others. She rides for friends, family, coworkers, and all those affected by rare cancers.

Leave an 🧡 in the comments for Prena!

04/22/2026

“When it comes to men’s health, I find that men are so shy to speak up about anything physical or mental,” says Michael, an MSK testicular cancer patient.

📽️ Hear more from Michael about his mission and why he feels passionate about paying it forward.

For many patients at MSK, a visit from a Caring Canine is a moment to pause, smile, and feel a little more at ease.These...
04/22/2026

For many patients at MSK, a visit from a Caring Canine is a moment to pause, smile, and feel a little more at ease.

These therapy dogs, alongside their dedicated handlers, help bring comfort and connection to MSK patients, caregivers, and staff each day. This National Volunteer Week, we’re proud to recognize the MSK Caring Canines who make these moments possible. 🐾

Interested in joining the MSK Caring Canines team? Join our open house information session (handlers only, no canines please).

📅 Wednesday, May 6
⏰ 6–7 p.m.
📍 417 East 68 Street, Room 151
To RSVP, email Jane at kopelmaj@mskcc.org

MSK gastrointestinal medical oncologist Dr. Eileen O'Reilly led a very promising phase 1/2 clinical trial of the targete...
04/21/2026

MSK gastrointestinal medical oncologist Dr. Eileen O'Reilly led a very promising phase 1/2 clinical trial of the targeted RAS therapy daraxonrasib for people facing pancreatic cancer, including MSK patient Leanna Stokes. Clinical trials nurse Tiffany Upshaw is also part of the team of MSK specialists who conducted the trial.

"This drug is potentially going to be a landmark shift in how we treat pancreatic cancer," says Dr. O'Reilly. “The ability to target RAS mutations that drive so much of pancreatic cancer is huge and has been missing from our treatments.”

Learn more about the research, which was presented at the 2026 American Association for Cancer Research Annual Meeting: https://bit.ly/4mMqjJ5

Donna was diagnosed with pancreatic cancer at age 66 when she and her husband were visiting one of their daughters in Au...
04/20/2026

Donna was diagnosed with pancreatic cancer at age 66 when she and her husband were visiting one of their daughters in Australia. When they returned to the U.S., they immediately came to MSK for care, where she learned she was eligible for an investigational vaccine trial, to prevent pancreatic cancer from returning after surgery.

MSK hepatopancreatobiliary surgeon Dr. Jeffrey Drebin, physician-scientist Dr. Vinod Balachandran, and medical oncologist Dr. Eileen O’Reilly walked Donna through each step.

“They described how they would take part of my tumor to make a personalized vaccine, and it sounded amazing,” Donna says. “My husband and I had a moment of concern about delaying chemotherapy, but all the doctors made me feel so comfortable that we took the leap of faith and said, ‘Go for it.’”

Over the next few months, Donna received an immunotherapy drug and eight doses of the vaccine, followed by chemotherapy, and then a final vaccine dose.

Today, Donna is 72 and recently celebrated her 50th anniversary with her husband in Sicily and spends as much time as she can with her daughters and six grandchildren.

Learn more about this clinical trial, presented at the 2026 American Association for Cancer Research Annual Meeting: https://bit.ly/41E31eN

🎙️A sincere thank you to all of the brilliant performers and guests who made MSK's Comedy vs Cancer benefit show such a ...
04/20/2026

🎙️A sincere thank you to all of the brilliant performers and guests who made MSK's Comedy vs Cancer benefit show such a success, including Nick Kroll, Hasan Minhaj, Zarna Garg, Bridget Everett, and Brett Goldstein.

While the evening was filled with laughter, the result was serious progress: every ticket sold helps fuel the breakthrough research that defines the future of oncology.

This year's event raised more than $2.5 million - with a lifetime amount of $9.8 million raised - and proceeds will support lifesaving blood cancer research at MSK. ⁣

Swipe through for some memories from the night. 💙

At MSK, we’re proud to have a dedicated team of over 500 volunteers across our New York and New Jersey locations. Every ...
04/20/2026

At MSK, we’re proud to have a dedicated team of over 500 volunteers across our New York and New Jersey locations. Every day, they show up for our patients, visitors, and staff, whether assisting with transport, supporting care teams, or simply lifting spirits.

Their compassion is at the heart of our community, and we’re grateful for all that they do. This National Volunteer Week, we’re celebrating the people who show up for our patients, caregivers, and staff in ways that truly matter.

Swipe to hear from a few of them in their own words:

🔵 Image 1: “Small moments of comfort or joy can meaningfully shape someone’s day.” - Maria
🔵 Image 2: “Connecting with patients became what I looked forward to most each week.” - Antonio
🔵 Image 3: “It’s not about being a magician or a hero—it’s about being there: being present, being consistent.” - Evan
🔵 Image 4: “Noticing Archie’s impact helped me connect with people—and those small moments can really keep you going.” - Leslie
🔵 Image 5: “I've learned how powerful even simple gestures can make a lasting difference in someone’s life.” - Jonathan

Learn how to become a volunteer at MSK: https://bit.ly/42dlBuh

Phase 1 trial results for a therapeutic mRNA vaccine for pancreatic cancer, led by MSK physician-scientist Dr. Vinod Bal...
04/19/2026

Phase 1 trial results for a therapeutic mRNA vaccine for pancreatic cancer, led by MSK physician-scientist Dr. Vinod Balachandran, included 16 patients who received the investigational vaccine called autogene cevumeran after pancreatic cancer surgery, along with an immunotherapy drug (called a checkpoint inhibitor) and chemotherapy.

The results are being presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting. Read more via NBC Nightly News with Tom Llamas ⬇️

🚨 An experimental, personalized vaccine using messenger RNA (mRNA) to prevent pancreatic cancer from returning after sur...
04/19/2026

🚨 An experimental, personalized vaccine using messenger RNA (mRNA) to prevent pancreatic cancer from returning after surgery continues to show promise in a small, 16-person patient group.

New results from a phase 1 clinical trial, being presented at the 2026 American Association for Cancer Research, show that nearly 90% of people whose immune systems responded to the vaccine were still alive six years later.

“These early results show this new immunotherapy approach has the potential to be groundbreaking for one of the deadliest cancers,” says MSK physician-scientist Dr. Vinod Balachandran, the trial’s principal investigator and Director of The Olayan Center for Cancer Vaccines.

Learn more about these findings: https://bit.ly/41E31eN

04/18/2026

🚨 Bad News for Cancer from the 2026 American Association for Cancer Research Annual Meeting:

Hear from MSK gastrointestinal medical oncologist Dr. Michael Foote, as he shares new research from a small (8-person) phase 2 clinical trial that found half of re**al patients with high HER2 saw their tumors disappear with targeted therapies and chemotherapy, meaning they didn't need surgery or in most cases even radiation.

Read more about the research: https://bit.ly/4sB03CB

**alcancer

Address

New York, NY

Telephone

+13477989213

Website

Alerts

Be the first to know and let us send you an email when Memorial Sloan Kettering Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Memorial Sloan Kettering Cancer Center:

Shortcuts

Featured

Share

Category